Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

PDUFA First: Fees To Support US FDA Device Center Staff

Executive Summary

To enhance combination product reviews, drug-fee revenue will pay for related positions in the agency's Center for Devices and Radiological Health.


Related Content

Interview: Putting The Pieces Together For Combo Products Oversight
FDA's Combo Products Review Transformation Begins
Industry, US FDA Strike $1Bn Deal After Contentious User-Fee Negotiations
FDA's Breakthrough Workload Will Be Eased By Hiring Reviewers With PDUFA VI Funds
Will Combination Products Join The User Fee Family?
Show Me The Money: Salaries, Red Tape Challenge FDA Recruiting
Industry, FDA Agree On Draft User Fee Commitment Letter